Navigation Links
MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
Date:10/20/2010

E and other currently available medicines.

About MAP Pharmaceuticals MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The Company is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the conduct and completion of clinical trials, and relating to the preparation and filing of a New Drug Application and the regulatory process to have the Company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended June 30
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
2. Inspiration Biopharmaceuticals OBI-1 Receives Orphan Drug Designation in Europe
3. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
4. Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
5. Transcept Pharmaceuticals to Host Conference Call to Discuss Preliminary Analysis of Intermezzo® Highway Driving Study
6. Transcept Pharmaceuticals to Present at Newsmakers in the Biotech Industry Conference
7. Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery
8. Excaliard Pharmaceuticals Appoints Thomas Wiggans to Chairman of the Board
9. ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™
10. Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration
11. ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
(Date:12/24/2014)... Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... is proud to announce Jennifer Hagerman , Pharm.D., ... will take office as the president of the Michigan ... ceremony will take place Feb. 28, 2015, at the ... at the Renaissance Center in Detroit, Michigan ...
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, ... of over-the-counter (OTC) medicinal and healthcare products, announced it ... MigraPure® H, a hemp-based, advanced headache relief product, for ... in Colorado , Washington ... With the MigraPure H Advanced headache relief ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... MUNDELEIN, Ill. , July 20 ... and information systems technology, today announced the addition of ... Sysmex hematology product offering.  The DM1200 enables Sysmex America ... analysis, which improves both the quality of results and ...
... Mich. , July 20 Two southeast Michigan ... in the region.  Delphinus Medical Technologies and Quantum Signal were approved today for ... of Michigan . , , , ... Arbor region continues to be a magnet for growing, high tech companies," ...
Cached Medicine Technology:Sysmex America Begins Distribution of CellaVision® DM1200 2Sysmex America Begins Distribution of CellaVision® DM1200 3Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area 2Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area 3
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding ... new selection of black one-shoulder cocktail dresses . In ... are available at discounted prices, up to 70% off. ... for three weeks only. You know, we have thousands of ... in our new items can visit our website for more ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the business ... company announces big discounts on its bamboo mats ... BambooFlooringChina.com is the world’s leader in bamboo flooring. According ... Jan. 20, 2015. , The bamboo mats are made ... thread. All the bamboo strips for the mats are ...
(Date:12/25/2014)... Miami, FL (PRWEB) December 25, 2014 When ... often find themselves in a frenzy to get rid of ... classroom. But families in Coral Gables now have the solution ... its second salon clinic location, Lice Troopers provides full spectrum ... in the Coral Gable area, including Sunset, Key Biscayne, Brickell, ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... receive effective, less expensive care from a clinic that functions ... of dedicated health care professionals, a new study shows. ... either hospitalization or a trip to the emergency room when ... the University of Texas in Houston versus usual care, according ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... say, but alternatives may help some , , MONDAY, May 18 ... the other an appliance that adjusts the jaw -- might ... treat. , In sleep apnea, the upper airway becomes blocked, ... 20-second bouts that can occur 30 or more times an ...
... Air Products (NYSE: APD ) today announced ... to Landauer-Metropolitan, Inc. (LMI), the largest provider of durable ... based in Mount Vernon, N.Y. Terms of the ... interests in certain of the companies previously operated as ...
... May 18 History was made on May 13, ... legislation allowing a "mid-level" oral health provider into state ... Advanced Dental Hygiene Practitioner (ADHP) model to become licensed ... overwhelmingly passed Senate File 2083, a bill establishing the ...
... of BCBSM Have Been Conducted Since 2006DETROIT, May 18 ... Shield of Michigan by the Michigan Office of Financial ... Blues financial statements over the audit,s four-year period. The ... Blues in a cycle in accordance with guidelines and ...
... Biotechnologies ( www.epeiusbiotech.com ) today announced the ... anti-cancer agent designed to seek-out and destroy metastatic cancers ... currently approved for the treatment of all solid tumors ... conducting a series of advanced Phase I/II studies and ...
... 18 A medication that helps stop the growth ... some patients with aggressive thyroid cancer, research from ... of the American Society of Clinical Oncology ... about two-thirds of 37 patients with aggressive differentiated thyroid ...
Cached Medicine News:Health News:New Options Offered for Sleep Apnea 2Health News:New Options Offered for Sleep Apnea 3Health News:New Options Offered for Sleep Apnea 4Health News:Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan 2Health News:Minnesota Passes Legislation Allowing Mid-level Oral Health Provider 2Health News:Minnesota Passes Legislation Allowing Mid-level Oral Health Provider 3Health News:State Audit of Blue Cross Blue Shield of Michigan Shows Company in Compliance with State and National Accounting Guidelines 2Health News:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009 2Health News:Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report 2Health News:Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report 3
... the Haemonetics OrthoPAT system collects and cleanses ... surgery, but it is the first product ... to the perioperative, intermittent blood loss of ... single-patient use disposable sets and an electromechanical ...
... Davol® pulsed lavage ... needed for quick, efficient ... bacteria, and foreign material. ... for optimal cleansing and ...
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
The UNI_CLIP® is a reliable and stable compression staple....
Medicine Products: